HF
PVLA

HRT Financial’s Palvella Therapeutics PVLA Stock Holding History

HRT Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-229
Closed -$5K – 3214
2023
Q3 		$5K Buy
+229
New +$4.92K ﹤0.01% 2189
2022
Q1 		– Sell
-1,626
Closed -$491K – 4015
2021
Q4 		$491K Buy
+1,626
New +$521K ﹤0.01% 1884
2021
Q3 		– Sell
-1,881
Closed -$576K – 3858
2021
Q2 		$576K Buy
+1,881
New +$412K 0.01% 1630
2019
Q4 		– Sell
-141
Closed -$38K – 1745
2019
Q3 		$38K Buy
+141
New +$54.6K ﹤0.01% 1316

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

HRT Financial's PVLA Position: Q4 2023 in Review

HRT Financial sold out of Palvella Therapeutics (PVLA) in Q4 2023, closing a stake of 229 shares — an estimated $5K sold.

HRT Financial first reported a position in PVLA in Q3 2019 and held it in 4 quarters. The position peaked at $576K in Q2 2021. 46 funds tracked by Wall St. Rank hold PVLA as of Q4 2023.

  • HRT Financial reported no remaining Palvella Therapeutics position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 229 Palvella Therapeutics shares in Q4 2023, an estimated $5K.
  • HRT Financial first reported a position in Palvella Therapeutics in Q3 2019 and held it in 4 quarters.
  • HRT Financial's Palvella Therapeutics position peaked at $576K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.